Small bowel review: Part I

Canadian Journal of Gastroenterology

Volumn 12, Issue 7, 1998, Pages 487-504

  Thomson, A B R ^a   Hasan, J ^b   Keelan, M ^a   Wild, G ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Acquired immune deficiency syndrome; Celiac disease; Clostridium difficile; Human immunodeffiency virus; Small bowel

Indexed keywords

BILE ACID; CYCLOSPORIN A; CYTOKINE; FATTY ACID BINDING PROTEIN; GLYCEROL; LIPOPROTEIN; OCTREOTIDE; ORAL REHYDRATION SOLUTION; SUBSTANCE P; TACROLIMUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; CELIAC DISEASE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CRYPTOSPORIDIOSIS; CYSTIC FIBROSIS; DIARRHEA; DOPPLER FLOWMETRY; GASTROENTEROLOGY; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; INTESTINE BLOOD FLOW; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; INTESTINE TRANSPLANTATION; LIPID ABSORPTION; NEUROLOGIC DISEASE; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; REVIEW; SMALL INTESTINE; SMALL INTESTINE ABSORPTION; WATER ABSORPTION;

EID: 0031763925     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/641278     Document Type: Review

References (226)

1. McGowan I, Anton P. AIDS and intestinal disease. Curr Opin Gastroenterol 1997;13:18-23.
2. Watson A, Samore MH, Wanke CA. Diarrhea and quality of life in ambulatory HIV-infected patients. Dig Dis Sci 1996;41:1794-800.
3. Bjarnason I, Sharpstone DR, Francis N, et al. Intestinal inflammation, ileal structure and function in HIV. AIDS 1996;10:1385-91.
4. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-7.
5. Alkhatib G, Combadiere C, Broder CC, et al. CC-CKR5: A RANTES, MIP-1, MIP-1 receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-8.
6. Heath SL, Tew JG, Szakal AK, Burton GF. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 1995;377:740-4.
7. Wilcox CM, Schwartz DA, Cotsonis G, Thompson SE. Chronic unexplained diarrhea in human immunodeficiency virus infection: determination of the best diagnostic approach. Gastroenterology 1996;110:30-7.
8. Blanshard C, Francis N, Gazzard BG. Investigation of chronic diarrhea in acquired immunodeficiency syndrome. A prospective study of 155 patients. Gut 1996;39:824-32.
9. Blackman E, Binder S, Gaultier C, Benveniste R, Cecilio M. Cryptosporidiosis in HIV-infected patients: diagnostic sensitivity of stool examination, based on number of specimens submitted. Am J Gastroenterol 1997;92:451-3.
10. Vakil NB, Schwartz SM, Buggy BP, et al. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 1996;334:19-23.
11. Cotte L, Drouet E, Bailly F, Vitozzi S, Denoyel GA, Trepo C. Cytomegalovirus DNA level on biopsy specimens during treatment of cytomegalovirus gastrointestinal disease. Gastroenterology 1996;111:439-44.
12. De Maar EF, Kleibeuker JH, Boersma-van Ek W, The TH, van Son WJ. Increased intestinal permeability during cytomegolovirus infection in renal transplant recipients. Transpl Int 1996;9:576-80.
13. Rabeneck L, Genta RM, Risser JMH, Bailey ME, Clarridge JE, Gyorkey F. Uncertain clinical significance of duodenal mucosal abnormalities in HIV-infected individuals. J Clin Gastroenterol 1996;23:11-4.
14. Sharpstone D, Rowbottom A, Francis N, et al. Thalidomide: a novel therapy for microsporidiosis. Gastroenterology 1997;112:1823-9.
15. Winter H. Gastrointestinal tract function and malnutrition in HIV-infected children. J Nutr 1996;126:2620S-2S.
16. MacAllan DC, Noble C, Baldwin C, et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995;333:83-8.
17. Mantyh CR, Pappas TN, Lapp JA, et al. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum. Gastroenterology 1996;111:1272-80.
18. Sternini C, Su D, Gamp PD, Bunnett NW. Cellular sites of expression of the neurokinin-1 receptor in the rat gastrointestinal tract. J Comp Neurol 1995;358:531-40.
19. Castagliuolo I, LaMont JT, Qiu B, Nikulasson ST, Pothoulakis C. A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileum. Gastroenterology 1996;111:433-8.
20. McClean P, Dodge JA, Nunn S, Carr KE, Sloan JM. Surface features of small intestinal mucosa in chidhood diarrheal disorders. J Pediatr Gastroenterol Nutr 1996;23:538-46.
21. Ilnyckyj A, Greenberg H, Bernstein CN. Escherichia coli 0157:H7 infection mimicking Crohn's disease. Gastroenterology 1997;112:995-9.
22. Giannella RA. Escherichia coli heat-stable enterotoxins, guanylins, and their receptors: what are they and what do they do? J Lab Clin Med 1995;125:173-81.
23. Scheving LA, Russell WE, Chong K-M. Structure, glycosylation, and localization of rat intestinal guanylyl cyclase C: modulation by fasting. Am J Physiol 1996;271:G959-68.
24. Savidge TC, Shmakov AN, Walker-Smith JA, Phillips AD. Epithelial cell proliferation in childhood enteropathies. Gut 1996;39:185-93.
25. Lencer WI, Moe S, Rufo PA, Madara JL. Transcytosis of cholera toxin subunits across model human intestinal epithelia. Proc Natl Acad Sci USA 1995;92:10094-8.
26. Benard O, Balasubramanian KA. Effect of enterotoxin on glutathione status in the intestinal mucosa. J Biochem Biophys 1996;33:409-13.
27. Qiu B, Pothoulakis C, Castagliuolo I, Nikulasson Z, LaMont JT. Nitric oxide inhibits rat intestinal secretion by Clostridium difficile toxin A but not Vibrio cholerae enterotoxin. Gastroenterology 1996;111:409-18.
28. Fasano A, Noriega FR, Liao FM, Wang W, Levine MM. Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. Gut 1997;40:505-11.
29. Dalton CB, Austin CC, Sobel J, et al. An outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk. N Engl J Med 1997;336:100-5.
30. Sarem F, Sarem-Damerdji LO, Nicolas JP. Comparison of the adherence of three Lactobacillus strains to Caco-2 and Int-407 human intestinal cell lines. Lett Appl Microbiol 1996;22:439-42.
31. Mao Y, Nobaek S, Kasravi B, et al. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 1996;111:334-44.
32. Cartwright-Shamoon J, Dickson GR, Dodge J, Carr KE. Uptake of yeast (Saccharomyces boulardii) in normal and rotavirus treated intestine. Gut 1996;39:204-9.
33. Matsui SM, Angel J. Viral infections of the gastrointestinal tract. Curr Opin Gastroenterol 1997;13:57-63.
34. Rickman LS, Freeman WR, Green WR, et al. Brief report: uveitis caused by Tropheryma whippelii. N Engl J Med 1995;332:363-6.
35. Schilling D, Adamek HE, Kaufmann V, Maier M, Riemann JF. Arthralgia as an early extraintestinal symptom of Whipple's disease. J Clin Gastroenterol 1997;24:18-20.
36. Von Herbay A, Ditton H-J, Maiwald M. Diagnostic application of a polymerase chain reaction assay for the Whipple's disease bacterium to intestinal biopsies. Gastroenterology 1996;110:1735-43.
37. Ramzan NN, Loftus E Jr, Burgart LJ, et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med 1997;126:520-7.
38. Müller C, Petermann D, Stain C, et al. Whipple's disease: comparison of histology with diagnosis based on polymerase chain reaction in four consecutive cases. Gut 1997;40:425-7.
39. Perdue MH, McKay DM. Mucosal regulators and immunopathophysiology. Curr Opin Gastroenterol 1996;12:591-9.
40. Fiocchi C. Cytokines and intestinal inflammation. Transplant Proc 1996;28:2442-3.
41. Madsen KL, Tavernini MM, Mosmann TR, Fedorak RN. Interleukin 10 modulates ion transport in rat small intestine. Gastroenterology 1996;111:936-44.
42. Jung HC, Eckmann L, Yang S, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995;95:55-65.
43. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995;376:177-80.
44. low CD4+ T cells. J Exp Med 1996;183:2669-74.
45. Jepson MA, Clark MA, Foster N, et al. Targeting to intestinal M cells. J Anat 1996;189:507-16.
46. Fló J, Elías F, Benedetti R, Massouh E. Reversible effects on B and T cells of the gut-associated lymphoid tissues in rats malnourished during suckling: impaired induction of the immune response to intra-Peyer patches immunization with cholera toxin. Clin Immunol Immunpathol 1996;80:147-54.
47. Wilson AD, Haverson K, Southgate K, Bland PW, Stokes CR, Bailey M. Expression of major histocompatibility complex class II antigens on normal porcine intestinal endothelium. Immunology 1996;88:98-103.
48. Kearsey JA, Stadnyk AW. Isolation and characterization of highly purified rat intestinal intraepithelial lymphocytes. J Immunol Methods 1996;194:35-48.
49. Kawaguchi-Miyashita M, Shimizu K, Nanno M, et al. Development and cytolytic function of intestinal intraepithelial T lymphocytes in antigen-minimized mice. Immunology 1996;89:268-73.
50. Seta-Tsukinowa. Regulation of complement C3 synthesis by interleukin-1 and transforming growth factor-beta in rat non-transformed intestinal epithelial cell line, IEC. J Gastroenterol 1996;31:633-8.
51. Teitelbaum DH, Del Valle J, Reyas B, et al. Intestinal intraepithelial lymphocytes influence the production of somatostatin. Surgery 1996;120:227-33.
52. Snijders F, Meenan J, Van den Blink B, Van Deventer SJG, Ten Kate FJW. Duodenal intraepithelial and lamina propria T lymphocytes in human immunodeficiency virus-infected patients with and without diarrhea. Scand J Gastroenterol 1996;31:1176-81.
53. Nilssen DE, Müller F, Øktedalen O, et al. Intraepithelial/T cells in duodenal mucosa are related to the immune state and survival time in AIDS. J Virol 1996;70:3545-50.
54. Roberts AI, Bilenker M, Ebert EC. Intestinal intraepithelial lymphocytes have a promiscuous interleukin-8 receptor. Gut 1997;40:333-8.
55. Hogaboam CM, Snider DP, Collins ST. Cytokine modulation of T-lymphocyte activation by intestinal smooth muscle cells. Gastroenterology 1997;112:1986-95.
56. Powers DC, McElhaney JE, Florenda OA Jr, et al. Humoral and cellular immune responses following vaccination with purified recombinant hemaglutinin from influenza A (H3N2) virus. J Infect Dis 1997;175:342-51.
57. Michalsky MP, Deitch EA, Ding J, Lu Q, Huang Q. Interleukin-6 and tumor necrosis factor production in an enterocyte cell model (Caco-2) during exposure to Escherichia coli. Shock 1997;7:139-46.
58. Miura S, Tsuzuki Y, Kurose I, et al. Endotoxin stimulates lymphocyte-endothelial interactions in rat intestinal Peyer's patches and villus mucosa. Am J Physiol 1996;271:G282-92.
59. Quigley EMM. Small intestinal transplantation: reflections on an evolving approach to intestinal failure. Gastroenterology 1996;110:2009-12.
60. Yedidag EN, Fryer JP, Levi E, et al. Early histopathology of small intestinal discordant xenografts. Transplantation 1996;62:1385-91.
61. Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplantation. Gastroenterology 1996;110:1820-34.
62. Rahman MS, Taguchi T, Nakao M, Yamada T, Suita S. Morphologic and functional comparison of jejunal and ileal segmental grafts in rat small intestinal transplantation: long-term results. Transplant Proc 1996;28:2551.
63. Nüssler NC, Cicalese L, Hoffman RA, et al. CD8+ host cells infiltrate the intestinal mucosa after allogeneic small bowel transplantation even in the abscence of acute rejection. Transplant Proc 1996;28:2456.
64. Sullivan B, Cohen Z, Fu X-M, et al. Graft-infiltrating cells in rats receiving orthotopic semiallogeneic small intestine transplantation with portal or systemic venous drainage. Transplantation 1996;62:715-21.
65. Miura S, Fukumura K, Kurose I, et al. Roles of ET-1 in endotoxin-induced microcirculatory disturbance in rat small intestine. Am J Physiol 1996;271:G461-9.
66. Wallis G, Brackett D, Lerner M, et al. In vivo spin trapping of nitric oxide generated in the small intestine, liver, and kidney during the development of endotoxemia: a time-course study. Shock 1996;6:274-8.
67. Wells CL. Colonization and translocation of intestinal bacterial flora. Transplant Proc 1996;28:2653-6.
68. Spada M, Alessiani M, Fabbi M, et al. Bacterial translocation is enhanced in pig intestinal transplantation when the colon is included in the graft. Transplant Proc 1996;28:2658-9.
69. Pirenne J, Benedetti E, Gruessner A, et al. Combined transplantation of small and large bowel. Transplantation 1996;61:1685-94.
70. Lòpez F, Hernandez G, Castillo L, et al. Effect of antibiotic luminal flushing on bacterial translocation: experimental study in small bowel autotransplantation in dogs. Transplant Proc 1996;28:2642-3.
71. Kuo RC, Marks WH, Lieberman JM, Johnson DL, Alfrey EJ, Dafoe DC. Systemic inflammatory response syndrome after human syngeneic intestinal transplantation: evidence for disruption of enterocyte barrier function. Transplant Proc 1996;28:2763-4.
72. Kanda T, Fujii H, Tani T, et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 1996;110:339-43.
73. Sarr MG. Motility and absorption in the transplanted gut. Transplant Proc 1996;28:2535-9.
74. Hamada N, Hutson WR, Nakada K, et al. Intestinal neuromuscular function after preservation and transplantation. J Surg Res 1996;63:460-6.
75. Costa A, Alessiani M, De Ponti F, et al. Stimulatory effect of FK506 and erythromycin on pig intestinal motility. Transplant Proc 1996;28:2571-2.
76. Cicalese L, Weber K, Lee RG, Rakela J, Tabasco-Minguillán J. Effect of FK506 on the mucosal perfusion of the rat intestinal allograft. Transplant Proc 1996;28:2575.
77. Oishi AJ, Inoue Y, Souba WW, Sarr MG. Alterations in carrier-mediated glutamine transport after a model of canine jejunal autotransplantation. Dig Dis Sci 1996;41:1915-24.
78. Winkler GB, Smith LJ, Sigalet DL. Fat absorption following small intestinal transplantation. Transplant Proc 1996;28:2544.
79. Saito T, Kobayashi E, Kaneko K, Miyata M, Fujimura A. Lipid absorption of the allointestinal grafts under a short course of methyldeoxysupergualin. Transplant Proc 1996;28:2570.
80. Terao T, Hisanaga E, Sai Y, Tamai I, Tsuji A. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. J Pharm Pharmacol 1996;48:1083-9.
81. Vanner S, Surprenant A. Neural reflexes controlling intestinal microcirculation. Am J Physiol 1996;271:G223-30.
82. Tsuruma T, Yagihashi A, Hirata K, et al. Evaluation of plasma IL-8 (CINC) concentration during ischemia and after reperfusion in the small intestine. Transplant Proc 1996;28:1917-8.
83. Fukumura D, Miura S, Kurose I, et al. IL-1 is an important mediator for microcirculatory changes in endotoxin-induced intestinal mucosal damage. Dig Dis Sci 1996;41:2482-92.
84. McCarthy-Pastores S, Katz DP, Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. Am J Gastroenterol 1996;91:1697-710.
85. Fan WQ, Smolich JJ, Wild J, Yu VYH, Walker AM. Nitric oxide modulates regional blood flow differences in the fetal gastrointestinal tract. Am J Physiol 1996;271:G598-604.
86. Bohlen HG, Lash JM. Intestinal absorption of sodium and nitric oxide-dependent vasodilation interact to dominate resting vascular resistance. Circ Res 1996;78:231-7.
87. Schleiffer R, Raul F. Prophylactic administration of L-arginine improves the intestinal barrier function after mesenteric ischaemia. Gut 1996;39:194-8.
88. Kreienberg PB, Darling RC III, Shah DM, Vincent PA, Blumenstock FA. ATP-MgC12 reduces intestinal permeability during mesenteric ischemia. J Surg Res 1996;66:69-74.
89. Miyauchi T, Tomobe Y, Ishikawa T, Goto K, Sugishita Y. Vasoconstriction by endothelin-1 in resistance and conduit portions of isolated human mesenteric arteries. Eur J Pharmacol 1996;303:193-6.
90. Åneman A, Medbak S, Watson D, Haglind E. Met-enkephalin and catecholamine release during feline intestinal ischemia-reperfusion. Shock 1996;4:4334-439.
91. LeGrand TS, Aw TY. Chronic hypoxia, glutathione-dependent detoxication, and metabolic instability in rat small intestine. Am J Physiol 1997;272:G328-34.
92. Ikai M, Itoh M, Joh T, Yokoyama Y, Odada N, Okada H. Complement plays an essential role in shock following intestinal ischemia in rats. Clin Exp Immunol 1996;106:156-9.
93. Pujic Z, Matsumoto I, Yamataka A, Miyano T, Wilce P. Induction of immediate-early, ornithine decarboxylase and antizyme gene expression in the rat small intestine after transient ischaemia. Life Sci 1996;58:2289-96.
94. Sonnino RE, Pigatt L, Schrama A, Burchett S, Franson R. Phospholipase A, secretion during intestinal graft ischemia. Dig Dis Sci 1997;42:972-81.
95. 1 on acute ischemia-reperfusion of canine small intestine. J Clin Biochem Nutr 1996;21:39-44.
96. Maconi G, Imbesi V, Porro GB. Doppler ultrasound measurement of intestinal blood flow in inflammatory bowel disease. Scand J Gastroenterol 1996;31:590-3.
97. Battarbee HD, Grisham MB, Johnson GG, Zavecz HJ. Superior mesenteric artery blood flow and indomethacin-induced intestinal injury and inflammation. Am J Physiol 1996;271:G605-12.
98. Frager D, Baer JW, Medwid SW, Rothpearl A, Bossart P. Detection of intestinal ischemia in patients with acute small-bowel obstruction due to adhesions or hernia: efficacy of CT. AJR Am J Roentgenol 1996;166:67-71.
99. Taourel PG, Fabre J-M, Pradel JA, et al. Value of CT in the diagnosis and management of patients with suspected acute small-bowel obstruction. AJR Am J Roentgenol 1995;165:1187-92.
100. Taourel PG, Deneuville M, Pradel JA, Regent D, Bruel JM. Acute mesenteric ischemia: diagnosis with contrast-enhanced CT. Radiology 1996;199:632-6.
101. Teefey SA, Roarke MC, Brink JA, et al. Bowel wall thickening: differentiation of inflammation from ischemia with color Doppler and duplex US. Radiology 1996;198:547-51.
102. Bielefeldt K, Conklin JL. Intestinal motility during hypoxia and reoxygenation in vitro. Dig Dis Sci 1997;42:878-84.
103. Golino A, Crawford EM, Gathe JC, Dekmezian RH. Recurrent small bowel infarction associated with antithrombin deficiency. Am J Gastroenterol 1997;92:323-5.
104. MacLeod RJ, Hamilton JR. Activation of Na+/H+ exchange is required for regulatory volume decrease after modest "physiological" volume increases in jejunal villus epithelial cells. J Biol Chem 1996;271:23138-45.
105. + exchanger NHE3 isoform. J Biol Chem 1996;271:3590-9.
106. + exchanger isoforms NHE-1, NHE-2, and NHE-3 mRNA. Am J Physiol 1996;271:G483-93.
107. + exchange mediates postprandial ileal water and electrolyte transport. Dig Dis Sci 1995;40:774-80.
108. Sundaram U, West AB. Effect of chronic inflammation on electrolyte transport in rabbit ileal villus and crypt cells. Am J Physiol 1997;272:G732-41.
109. + exchanger isoforms (NHE-1, -2, and -3) are differentially responsive to second messenger agonists of the protein kinase A and C pathways. J Biol Chem 1995;270:29209-16.
110. + exchanger isoform NHE3 are involved in stimulation and inhibition by protein kinases/growth factors. J Biol Chem 1995;270:13716-25.
111. 2+ responsiveness to the apical isoform NHE3. J Biol Chem 1995;270:26460-5.
112. 3 exchanger during intestinal development. Am J Physiol 1996;271:G330-7.
113. D'Andrea L, Lytle C, Matthews JB, et al. Na:K:2C1 cotransporter (NKCC) of intestinal epithelial cells: surface expression in response to cAMP. J Biol Chem 1996;271:28969-76.
114. + exchange. J Biol Chem 1996;271:9919-27.
115. Bearcroft CP, Perrett D, Farthing MJG. 5-hydroxytryptamine release into human jejunum by cholera toxin. Gut 1996;39:528-31.
116. Franks CM, Hardcastle J, Hardcastle PT. Neural involvement in 5-hydroxytryptamine-induced net electrogenic ion secretion in the rat. intestine in vivo. J Pharm Pharmacol 1996;48:411-6.
117. Sanger GJ. 5-Hydroxytryptamine and functional bowel disorders. Neurogastroenterol Mot 1996;8:319-31.
118. Agrons GA, Corse WR, Markowitz RI, Suarez ES, Perry DR. Gastrointestinal manifestations of cystic fibrosis: radiologic pathologic correlation. Radiographics 1996;16:871-93.
119. Teune TM, Timmers-Reker AJM, Bouquet J, Bijman J, De Jonge HR, Sinaasappel M. In vivo measurement of chloride and water secretion in the jejunum of cystic fibrosis patients. Pediatr Res 1996;40:522-7.
120. Ameen NA, Ardito T, Kashgarian M, Marino CR. A unique subset of rat and human intestinal villus cells express the cystic fibrosis transmembrane conductance regulator. Gastroenterology 1995;108:1016-23.
121. Valverde MA, O'Brien JA, Sepúlveda FV, Ratcliff RA, Evans MJ, Colledge WH. Impaired cell volume regulation in intestinal crypt epithelia of cystic fibrosis mice. Proc Natl Acad Sci USA 1995;92:9038-41.
122. Van Kuijck MA, Vamn Aubel RAMH, Busch AE, et al. Molecular cloning and expression of a cyclic AMP-activated chloride conductance regulator: a novel ATP-binding cassette transporter. Proc Natl Acad Sci USA 1996;93:5401-6.
123. Lang ME, Davison JS, Bates SL, Meddings JB. Opioid receptors on guinea-pig intestinal crypt epithelial cells. J Physiol 1996;497:161-74.
124. Farthing MJG. The role of somatostatin analogues in the treatment of refractory diarrhea. Digestion 1996;57:107-13.
125. Harris AG, O'Dorisio TM, Woltering EA, et al. Consensus statement: octreotide dose titration in secretory diarrhea. Dig Dis Sci 1995;40:1464-73.
126. Rozé C, Molis C, Fu-Cheng X, Ropert A, Geneve J, Galmiche JP. Peptide YY inhibition of prostaglandin-induced intestinal secretion is haloperidol-sensitive in humans. Gastroenterology 1997;112:1520-8.
127. Quin JA, Sgambati SA, Goldenring JR, et al. PYY inhibition of VIP-stimulated ion transport in the rabbit distal ileum. J Surg Res 1995;58:111-5.
128. McKay DM, Berin MC, Fondacaro JD, Perdue MH. Effects of neuropeptide Y and substance P on antigen-induced ion secretion in rat jejunum. Am J Physiol 1996;271:G987-92.
129. Mourad FH, O'Donnell LHD, Andre EA, et al. L-Arginine, nitric oxide, and intestinal secretion: studies in rat jejunum in vivo. Gut 1996;39:539-44.
130. Fedorak RN. Antidiarrheal therapy. In: Friedman G, ed. Gastrointestinal Pharmacology and Therapeutics. Philadelphia: Lippincott-Raven Publishers, 1997:175-92.
131. Schiller LR, Santa Ana CA, Porter J, Fordtran JS. Glucose-stimulated sodium transport by the human intestine during experimental cholera. Gastroenterology 1997;112:1529-35.
132. Whang EE, Dunn JC, Mahanty H, McFadden DW, Zinner MJ, Ashley SW. Endotoxin inhibitor prevents sepsis-induced alterations in intestinal ion transport. Am J Surg 1996;172:341-4.
133. Molina S, Vettorazzi C, Peerson JM, Solomons NW, Brown KH. Clinical trial of glucose-oral rehydration solution (ORS), rice dextrin-ORS, and rice flour-ORS for the management of children with acute diarrhea and mild or moderate dehydration. Pediatrics 1995;95:191-7.
134. Multicentre evaluation of reduced-osmolarity oral rehydration salts solution. International Study Group on Reduced-osmolarity ORS solutions. Lancet 1995;345:282-5.
135. MacLeod RJ, Bennett HP, Hamilton JR. Inhibition of intestinal secretion by rice. Lancet 1995;346:90-2.
136. Islam S, Mahalanabis D, Chowdhury AKA, Wahed MA, Rahman ASMH. Glutamine is superior to glucose in stimulating water and electrolyte absorption across rabbit ileum. Dig Dis Sci 1997;42:420-3.
137. Santosham M, Fayad I, Zikri MA, Hussein A, Amponsah A. A double-blind clinical trial comparing World Health Organization oral rehydration solution with a reduced osmolarity solution containing equal amounts of sodium and glucose. J Pediatr 1996;128:45-51.
138. Wapnir RA, Wingertzahn MA, Moyse J, Teichberg S. Gum arabic promotes rat jejunal sodium and water absorption from oral rehydration solutions in two models of diarrhea. Gastroenterology 1997;112:1979-85.
139. 2-adrenoceptors in the regulation of intestinal water transport. Br J Pharmacol 1997;120:892-8.
140. Prezmioslo RT, Lundin KE, Sollid LM, Nelufer J, Ciclitira PJ. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut 1995;36:874-9.
141. Beckett CG, Dell'Olio D, Kontakou M, Przemioslo RT, Rosen-Bronson S, Ciclitira PJ. Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with celiac disease. Gut 1996;39:818-23.
142. Kontakou M, Przemioslo RT, Sturgess RP, et al. Cytokine mRNA expression in the mucosa of treated celiac patients after wheat peptide challenge. Gut 1995;37:52-7.
143. Shidrawi RG, Day P, Przemioslo R, Ellis HJ, Nelufer JM, Ciclitira PJ. In vitro toxicity of gluten peptides in celiac disease assessed by organ culture. Scand J Gastroenterol 1995;30:758-63.
144. Štěpánková R, Tlaskalová-Hogenová H, Šinkora J, Jodl J, Frič P. Changes in jejunal mucosa after long-term feeding of germfree rats with gluten. Scand J Gastroenterol 1996;31:551-7.
145. Nilsen EM, Gjertsen HA, Jensen K, Brandtzaeg P, Lundin KEA. Gluten activation of peripheral blood T cells induces a Th0-like cytokine pattern in both celiac patients and controls. Clin Exp Immunol 1996;103:295-303.
146. Oberhuber G, Vogelsang H, Stolte M, Muthenthaler S, Kummer AJ, Radaszkiewicz T. Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis. Am J Pathol 1996;148:1351-7.
147. Troncone R, Greco L, Mayer M, et al. In siblings of celiac children, rectal gluten challenge reveals gluten sensitization not restricted to celiac HLA. Gastroenterology 1996;111:318-24.
148. Marquez MG, Roux ME. Intestinal intraepithelial lymphocytes are influenced by luminal antigens. Comunicaciones Biologicas 1995;13:313-9.
149. Maiuri L, Picarelli A, Boirivant M, et al. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996;110:1368-78.
150. Lundin KEA, Sollid LM, Anthonsen D, et al. Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology 1997;112:752-9.
151. Moss SF, Attia L, Scholes JV, Walters JRF, Holt PR. Increased small intestinal apoptosis in celiac disease. Gut 1996;39:811-7.
152. Nakshabendi IM, Downie S, Russell RI, Rennie MJ. Increased rates of duodenal mucosal protein synthesis in vivo in patients with untreated celiac disease. Gut 1996;39:176-9.
153. Challacombe DN. Screening tests for celiac disease. Arch Dis Childhood 1995;73:3-7.
154. Sategna-Guidetti C, Grosso S, Bruno M, Bruna-Grosso S. Reliability of immunologic markers of celiac sprue in the assessment of mucosal recovery after gluten withdrawal. J Clin Gastroenterol 1996;23:101-4.
155. Cataldo F, Ventura A, Lazzari R, Balli F, Nassimbeni G, Marino V. Antiendomysium antibodies and celiac disease: solved and unsolved questions. An Italian multicentre study. Acta Paediatr 1995;84:1125-31.
156. Troncone R, and the SIGEP Working Group on Latent Celiac Disease. Latent celiac disease in Italy. Acta Paediatr 1995;84:1252-7.
157. Volta U, Molinaro N, De Franceschi L, Bianco-Bianchi F. Human umbilical cord as substrate for IgA antiendomysial antibodies allows large scale screening for celiac sprue. J Clin Gastroenterol 1996;23:18-20.
158. Catassi C, Ratsch IM, Fabiani E, et al. High prevalence of undiagnosed celiac disease in 5280 Italian students screened by antigliadin antibodies. Acta Pediatr 1995;84:672-6.
159. Hadjivassiliou M, Gibson A, Davies-Jones GAB, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? Lancet 1996;347:369-71.
160. Gale L, Wimalaratna, Brotodiharjo A, Duggan JM. Down's syndrome is strongly associated with celiac disease. Gut 1997;40:492-6.
161. Catassi C, Fabiani E, Rätsch IM, et al. Is the sugar intestinal permeability test a reliable investigation for celiac disease screening? Gut 1997;40:215-7.
162. Smecuol E, Bai JC, Vazquez H, et al. Gastrointestinal permeability in celiac disease. Gastroenterology 1997;112:1129-36.
163. Iqbal ITH, Lewis KO, Gearty JC, Cooper BT. Small intestinal permeability to mannitol and lactulose in the three ethnic groups resident in West Birmingham. Gut 1996;39:199-203.
164. Teahon K, Somasundaram S, Smith T, Menzies I, Bjarnason I. Assessing the site of increased intestinal permeability in celiac and inflammatory bowel disease. Gut 1996;38:864-9.
165. Strocchi A, Corazza G, Furné J, et al. Measurements of the jejunal unstirred layer in normal subjects and patients with celiac disease. Am J Physiol 1996;270:G487-91.
166. Janatiunen EK, Pikkarainen PH, Kemppainen TA, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995;333:1033-7.
167. Smecuol E, Gonzalez D, Mautalen C, et al. Longitudinal study on the effect of treatment on body composition and anthropometry of celiac disease patients. Am J Gastroenterol 1997;92:639-43.
168. Corazza GR, Andreani ML, Biagi F, Bonvicini F, Bernardi M, Gasbarrini G. Clinical, pathological, and antibody pattern of latent celiac disease: report of three adult cases. Am J Gastroenterol 1996;91:2203-7.
169. Picarelli A, Maiuri L, Mazzilli MC, et al. Gluten-sensitive disease with mild enteropathy. Gastroenterology 1996;111:608-16.
170. Barlow JM, Johnson CD, Stephens DH. Celiac disease: How common is jejunoileal fold pattern reversal found at small-bowel follow-through? AJR Am J Roentgenol 1996;166:575-7.
171. Fine KD, Meyer RL, Lee EL. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology 1997;112:1830-8.
172. Carroccio A, Iacono G, Lerro P, et al. Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease. Gastroenterology 1997;112:1839-44.
173. O'Mahony S, Howdle PD, Losowsky MS. Review article: management of patients with non-responsive celiac disease. Aliment Pharmacol Ther 1996;10:671-80.
174. Ruan EA, Komorowski RA, Hogan WJ, Soergel KH. Nongranulomatous chronic idiopathic enterocolitis: clinicopathologic profile and response to corticosteroids. Gastroenterology 1996;111:629-37.
175. Dickey W, McConnell JB. How many hospital visits does it take before celiac sprue is diagnosed? J Clin Gastroenterol 1996;23:21-3.
176. Collin P, Vilska S, Heinonen PK, Hällström O, Pikkarainen P. Infertility and celiac disease. Gut 1996;39:382-4.
177. Corazza GR, Di Sario A, Cecchetti L, et al. Bone mass and metabolism in patients with celiac disease. Gastroenterology 1995;109:122-8.
178. Mautalen C, Gonzalez D, Mazure R, et al. Effect of treatment on bone mass, mineral metabolism, and body composition in untreated celiac disease patients. Am J Gastroenterol 1997;92:313-8.
179. McFarlane XA, Bhalla AK, Reeves DE, Morgan LM, Robertson DA. Osteoporosis in treated adult celiac disease. Gut 1995;36:710-4.
180. McFarlane XA, Bhalla AK, Robertson DAF. Effect of a gluten free diet on osteopenia in adults with newly diagnosed celiac disease. Gut 1996;39:180-4.
181. Bai JC, Gonzalez D, Mautalen C, et al. Long-term effect of gluten restriction on bone mineral density of patients with celiac disease. Aliment Pharmacol Ther 1997;11:157-64.
182. Collin P, Pukkala E, Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with celiac disease. Gut 1996;38:528-30.
183. Murray A, Cuevas EC, Jones DB, Wright DH. Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Am J Pathol 1995;146:509-19.
184. Besnard BP, Niot I, Bernard A, Carlier H. Cellular and molecular aspects of fat metabolism in the small intestine. Proc Nutr Soc 1996;55:19-37.
185. Amelsberg A, Schteingart CD, Stein J, et al. Intestinal absorption of sodium dodecyl sulfate in the rodent: evidence for paracellular absorption. Am J Physiol 1997;272:G498-506.
186. Poirier H, Degrace P, Niot I, Bernard A, Besnard P. Localization and regulation of the putative membrane fatty acid transporter (FAT) in the small intestine. Comparison with fatty acid binding proteins (FABP). Eur J Biochem 1996;238:368-73.
187. Hodson ME, Ponder JW, Cistola DP. The NMR solution structure of intestinal fatty acid binding protein complexed with palmitate: application of a novel distance geometry algorithm. J Mol Biol 1996;264:585-602.
188. Hsu K-T, Storch J. Fatty acid transfer from liver and intestinal fatty acid binding proteins to membranes occurs by different mechanisms. J Biol Chem 1996;271:13317-23.
189. Cistola DP, Kim K, Rogl H, Frieden D. Fatty acid interactions with a helix-less variant of intestinal fatty acid binding protein. Biochem 1996;35:7559-65.
190. Kim K, Cistola DP, Frieden C. Intestinal fatty acid binding protein: the structure and stability of a helix-less variant. Biochem 1996;35:7553-8.
191. Richieri GV, Ogata RT, Kleinfeld AM. Kinetics of fatty acid interactions with fatty acid binding proteins from adipocyte, heart and intestine. J Biol Chem 1996;271:11281-300.
192. Baier LJ, Bogardus C, Sacchettini JC. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 1996;271:10892-6.
193. Prows DR, Murphy EJ, Moncecchi D, Schroeder F. Intestinal fatty acid binding protein expression stimulates fibroblast fatty acid esterification. Chem Phys Lipids 1996;84:47-56.
194. Fontaine RN, Gossett RE, Schroeder F, Otoole BA, Doetschman T. Liver and intestinal fatty acid binding proteins in control and TGF beta 1 gene targeted deficient mice. Mol Cell Biochem 1996;159:149-53.
195. Murthy S, Mathur SN, Bishop WP, Field FJ. Inhibition of apolipoprotein B secretion by IL-6 is mediated by EGF or an EGF-like molecule in Caco-2 cells. J Lipid Res 1997;38:206-16.
196. Aldini R, Roda A, Montagnani M, Cerre C, Pellicciari R, Roda E. Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification. Steroids 1996;61:590-7.
197. +/bile acid cotransport system from rabbit ileum. Biochem J 1995;306:241-6.
198. Shneider BL, Dawson PA, Christie DM, Hardikar W, Wong MH, Suchy FJ. Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. J Clin Invest 1995;95:745-54.
199. Stengelin S, Apel S, Becker W, et al. The rabbit ileal lipid-binding protein. Gene cloning and functional expression of the recombinant protein. Eur J Biochem 1996;239:887-96.
200. Tsuchiya T, Kalogeris TJ, Tso P. Ileal transposition into the upper jejunum affects lipid and bile salt absorption in rats. Am J Physiol 1996;271:G581-91.
201. Chazouilléres O, Marteau P, Haniche M, Jian R, Poupon R. Ileal absorption of bile acids in patients with chronic cholestasis. Dig Dis Sci 1996;41:2417-22.
202. Hashimoto S, Igimi H, Uchida K, Satoh T, Benno Y, Takeuchi N. Effects of β-lactam antibiotics on intestinal microflora and bile acid metabolism in rats. Lipids 1996;31:601-9.
203. Engle MJ, Grove ML, Becich MJ, Mahmood A, Alpers DH. Appearance of surfactant-like particles in apical medium of Caco-2 cells may occur via tight junctions. Am J Physiol 1995;268:C1401-13.
204. Shamir R, Johnson WJ, Zolfaghari R, Lee HS, Fisher EA. Role of bile salt-dependent cholesteryl ester hydrolase in the uptake of micellar cholesterol by intestinal cells. Biochemistry 1995;34:5351-8.
205. Carr TP, Gallaher DD, Yang C-H, Hassel CA. Increased intestinal contents viscosity reduces cholesterol absorption efficiency in hamsters fed hydroxypropyl methylcellulose. J Nutr 1996;126:1463-9.
206. Overturf ML, Smith SA, Gotto AM Jr, et al. Dietary cholesterol absorption, and sterol and bile acid excretion in hypercholesterolemia-resistant while rabbits. J Lipid Res 1990;31:2019-27.
207. Pakarinen M, Miettinen TA, Lauronen J, et al. Adaptation of cholesterol absorption after proximal resection of porcine small intestine. J Lipid Res 1996;37:1766-75.
208. Nilsson A, Becker W. Uptake and interconversion of plasma unesterified n-3 polyunsaturated fatty acids by the GI tract of rats. Am J Physiol 1995;268:G732-8.
209. Melin T, Qi C, Nilsson A. Bile but not chyle lipoprotein is an important source of arachidonic acid for the rat small intestine. Prostaglandins Leukot Essent Fatty Acids 1996;55:337-43.
210. Field FJ, Born E, Mathur SN. Effect of micellar β-sitosterol on cholesterol metabolism in Caco-2 cells. J Lipid Res 1997;38:348-60.
211. Gugger ET, Erdman JW Jr. Intracellular β-carotene transport in bovine liver and intestine is not mediated by cytosolic proteins. J Nutr 1996;126:1470-4.
212. Duszka C, Grolier P, Azim E-M, Alexandre-Gouabau M-C, Borel P, Azais-Braesco V. Rat intestinal beta-carotene dioxygenase activity is located primarily in the cytosol of mature jejunal enterocyte. J Nutr 1996;126:2550-6.
213. Lin HC, Zhao X-T, Wang L. Fat absorption is not complete by midgut but is dependent on load of fat. Am J Physiol 1996;271:G62-7.
214. Nishimura M, Seishima M, Ohashi H, Noma A. Effects of lipid administration on lymphatic apolipoprotein A-IV and B output and synthesis. Am J Physiol 1996;271:G322-9.
215. Gonzalez-Vallina R, Wang H, Zhan R, et al. Lipoprotein and apolipoprotein secretion by a newborn piglet intestinal cell line (IPEC-1). Am J Physiol 1996;271:G249-59.
216. Sakata Y, Fujimoto K, Ogata S-I, et al. Postabsorptive factors are important for satiation in rats after a lipid meal. Am J Physiol 1996;271:G438-42.
217. Wang H, Zhan R, Hunter F, Du J, Black D. Effect of acute feeding of diets of varying fatty acid composition on intestinal apolipoprotein expression in the newborn swine. Pediatr Res 1996;39:1078-84.
218. Kalogeris TJ, Monroe F, Demichele SJ, Tso P. Intestinal synthesis and lymphatic secretion of apolipoprotein A-IV vary with chain length of intestinally infused fatty acids in rats. J Nutr 1996;126:2720-9.
219. Ginsberg GS, Ozer J, Karathanasis SK. Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4. J Clin Invest 1995;96:528-38.
220. Fong LG, Fujishima SE, Komaromy MC, Pak YK, Ellsworth JL, Cooper AD. Location and regulation of low-density lipoprotein receptors in intestinal epithelium. Am J Physiol 1995;269:G60-72.
221. Funahashi T, Giannoni F, DePaoli AM, Skarosi SF, Davidson NO. Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apo B mRNA editing. J Lipid Res 1995;36:414-28.
222. Pidlich J, Renner F, Ellinger A, Huttinger M, Pavelka M, Gangl A. Effect of pluronic L-81 on intestinal lipoprotein secretion in the rat. Dig Dis Sci 1996;41:1445-51.
223. Soued M, Mansbach CM II. Chylomicron remnant uptake by enterocytes is receptor dependent. Am J Physiol 1996;270:G203-12.
224. Levy E. The genetic basis of primary disorders of intestinal fat transport. Clin Invest Med 1996;195:317-24.
225. Kalogeris TJ, Gray L, Yeh YY, Tso P. Triacylglycerol and cholesterol transport during absorption of glycerol trioleate vs glycerol trielaidate. Am J Physiol 1996;270:G268-76.
226. Young SG, Cham CM, Pitas RE, et al. A genetic model for absent chylomicrone formation: mice producing apolipoprotein B in the liver, but not in the intestine. J Clin Invest 1995;96:2932-46.